Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply

Articolo

Data di Pubblicazione:

2018

Citazione:

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply / Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 48:5(2018), pp. 575-576. [10.1111/apt.14860]

Tipologia CRIS:

1.1 Articolo in rivista

Elenco autori:

Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S

Autori di Ateneo:

DANESE SILVIO

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/119938

Pubblicato in:

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Journal